Montana SB422 revises insurance coverage laws, requiring coverage for advanced metastatic cancer and associated conditions, prohibiting insurers from.
Montana SB422 generally revises laws relating to insurance coverage for advanced metastatic cancer and associated conditions. It mandates that insurers providing coverage for advanced metastatic cancer and associated conditions cannot require insured individuals to fail to respond to a different drug or prove a history of failure of a different drug before covering a prescription drug approved by the FDA.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.